Frequent allelic imbalance of tumor suppressor gene loci in cervical dysplasia

Int J Gynecol Pathol. 1999 Oct;18(4):374-80. doi: 10.1097/00004347-199910000-00013.

Abstract

In addition to human papillomavirus (HPV) infection, loss of heterozygosity (LOH) at tumor suppressor gene loci has been frequently observed in cervical cancer. Thus, it may be assumed that detection and characterization of specific LOH profiles in preneoplastic lesions, in addition to HPV typing, might facilitate assessment of progression risk of cervical dysplasia. In this study, the type and frequency of allelic imbalance (allelic loss or allelic reduction) were analyzed in 24 unrelated cervical lesions using 14 polymorphic microsatellite markers at different tumor suppressor gene loci. No allelic loss was observed in four condylomatous lesions, whereas 2 of 13 (15%) CIN I lesions displayed allelic loss at 3p25 and 5q11-13. In high-grade lesions, however, allelic loss occurred in four of six (66%) cases at multiple chromosomal regions (3p14-25, 5p15, 5q11, 5q21, 11p15, and 17q21). Allelic reduction was observed in 4 of 13 (30%) low-grade lesions and 3 of 6 (50%) high-grade lesions. LOH was confined to lesions infected by high-risk HPV types. These data suggest that chromosomal instability is an early event in cervical carcinogenesis. The detection of LOH on multiple chromosome 3p loci in 50% of high-grade lesions suggests that a specific marker panel encompassing this region might enable better assessment of which lesions are likely to regress, persist, or progress.

MeSH terms

  • Carcinoma / genetics*
  • Carcinoma / virology
  • Chromosome Mapping
  • Chromosomes, Human, Pair 17 / genetics
  • Chromosomes, Human, Pair 3 / genetics
  • Chromosomes, Human, Pair 5 / genetics
  • Condylomata Acuminata / genetics
  • Condylomata Acuminata / virology
  • Female
  • Genes, Tumor Suppressor / genetics*
  • Humans
  • Loss of Heterozygosity / genetics*
  • Microsatellite Repeats
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification
  • Polymerase Chain Reaction
  • Uterine Cervical Diseases / genetics
  • Uterine Cervical Diseases / virology
  • Uterine Cervical Dysplasia / genetics*
  • Uterine Cervical Dysplasia / virology
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / virology